Evidence map›Paper›PMID 40183391›Full record

ArticleCardiovascular research2025

Loss of conserved long non-coding RNA MIR503HG leads to altered NOTCH pathway signalling and left ventricular non-compaction cardiomyopathy.

João P Monteiro, Diptarka Saha, Ana-Mishel Spiroski, Saiba Mahesh, Peter Kaltzis, Abhijit Nadavallil, Vaibhao Janbandhu, Nicholas J Murray, Francesco Severi, Azzurra Laura De Pace and 15 more

Abstract read
In one paragraph

Article in Cardiovascular research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Elucidating Gene Functions in Congenital Heart Disease.Current treatment options in cardiovascular medicine · 2026
    Review
  6. Article
  7. TheNon-coding RNA · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

João P MonteiroCentre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK.ORCID 0000-0001-6481-6875
Diptarka SahaAustralian Regenerative Medicine Institute, 15 Innovation Walk, Monash University, Clayton, VIC 3800, Australia.
Ana-Mishel SpiroskiCentre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK.ORCID 0000-0002-8584-8048
Saiba MaheshAustralian Regenerative Medicine Institute, 15 Innovation Walk, Monash University, Clayton, VIC 3800, Australia.
Peter KaltzisAustralian Regenerative Medicine Institute, 15 Innovation Walk, Monash University, Clayton, VIC 3800, Australia.ORCID 0000-0003-2790-6606
Abhijit NadavallilAustralian Regenerative Medicine Institute, 15 Innovation Walk, Monash University, Clayton, VIC 3800, Australia.
Vaibhao JanbandhuVictor Chang Cardiac Research Institute, Darlinghurst, NSW 2010, Australia.ORCID 0000-0002-3837-1865
Nicholas J MurrayVictor Chang Cardiac Research Institute, Darlinghurst, NSW 2010, Australia.
Francesco SeveriCentre for Regenerative Medicine, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh EH16 4UU, UK.ORCID 0000-0003-2186-8274
Azzurra Laura De PaceCentre for Regenerative Medicine, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh EH16 4UU, UK.ORCID 0000-0003-2121-7068
Sandra Sánchez-EstebanCentre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK.
Julie RodorCentre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK.ORCID 0000-0003-2900-5780
Abdelaziz BeqqaliCentre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK.ORCID 0000-0003-1390-5821
Matthew BennettCentre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK.
Kevin StewartCentre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK.ORCID 0000-0003-4579-6826
Adrian ThomsonCentre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK.ORCID 0000-0001-7320-300X
Patrick W F HadokeCentre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK.ORCID 0000-0002-1041-1781
Dyana MarkoseCentre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh EH16 4UU, UK.ORCID 0000-0002-4739-8509
John R Wilson-KanamoriCentre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh EH16 4UU, UK.ORCID 0000-0002-1372-9912
Neil C HendersonCentre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh EH16 4UU, UK.ORCID 0000-0002-2273-4094
Dónal O'CarrollCentre for Regenerative Medicine, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh EH16 4UU, UK.
Thomas QuertermousDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.ORCID 0000-0002-7645-9067
Richard P HarveyVictor Chang Cardiac Research Institute, Darlinghurst, NSW 2010, Australia.ORCID 0000-0002-9950-9792
Gonzalo Del Monte-NietoAustralian Regenerative Medicine Institute, 15 Innovation Walk, Monash University, Clayton, VIC 3800, Australia.ORCID 0000-0003-3830-2226
Andrew H BakerCentre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK.ORCID 0000-0003-1441-5576

Funding

Australian Research Council DP210102134BHF/DHF/DZHKBritish Heart FoundationHeart Foundation of Australia Future Leader Fellowship 102036National Health and Medical Research Council 2021155National Health and Medical Research Council 2038886National Heart Foundation of Australia 102036
6 · The paper itself

Abstract

aimsThe highly conserved long non-coding RNA (lncRNA) MIR505HG has been primarily recognized as a precursor for microRNAs (miR)-424 and miR-503. However, studies have since demonstrated that MIR503HG has distinct functions from its associated miRNAs, playing important roles in cell proliferation, invasion, apoptosis, and differentiation. While these miRNAs are known to influence cardiomyocyte differentiation, the specific role of MIR503HG in heart development remains unexplored. We seek to determine how MIR503HG deletion impacts ventricular chamber development and to identify underlying molecular mechanisms. METHODS AND

resultsTo study the role of the lncRNA in vivo, we generated a functional MIR503HG knockout mouse model (MIR503HG-/-) using a synthetic polyadenylation signal to terminate MIR503HG transcription without affecting miR-424/503 expression. We performed morphological analyses on embryonic and adult hearts using microCT along with cardiac functional analysis via transthoracic echocardiography. We further apply single-nuclei RNA sequencing (snRNA-seq) on adult hearts to identify potential molecular mechanisms underlying the observed phenotypes. Functional deletion of MIR503HG alone was associated with reduced compact myocardium thickness and increased trabecular myocardium in the left ventricle (LV) at embryonic day 17.5 compared to wild-type mice, indicating a LV non-compaction (LVNC) phenotype. Moreover, adult MIR503HG-/- mutant hearts showed increased trabecular complexity, impaired LV relaxation, and mitral valve regurgitation. SnRNA-seq further revealed altered expression of several genes associated with cardiomyocyte function and LVNC, including Actc1, Mib1, Mybpc3, and Myh7. Lastly, Notch1 activity was also significantly increased in mutant hearts which has been previously associated with LVNC.

conclusionMIR503HG plays a role in ventricular chamber development, and its deletion leads to an LVNC phenotype independent of the miRNA cluster within its locus, highlighting its importance in cardiac development and disease. We further suggest that abnormal Notch1 activity may underpin the LVNC phenotype presented.

Indexed as

Isolated Noncompaction of the Ventricular MyocardiumMicroRNAsMyocytes, CardiacReceptor, Notch1Receptors, NotchRNA, Long NoncodingVentricular Function, LeftAnimalsDisease Models, AnimalGene Expression Regulation, DevelopmentalMice, Inbred C57BLMice, KnockoutPhenotypeSignal TransductionMicroRNAsNotch1 protein, mouseReceptor, Notch1Receptors, NotchRNA, Long NoncodingHeart developmentLeft ventricular non-compactionLong non-coding RNA

Identifiers

PMID40183391
PMCPMC12236064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.